NCT07517653 2026-04-08Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal MelanomaShanghai Zhongshan HospitalPhase 2 Not yet recruiting70 enrolled